Detail Information of Xenobiotics

General Information of Xenobiotics (ID: XEO01396)
Xenobiotics Name
HET-0016
Xenobiotics Type
Pharmaceutical Agent(s)
Classification
Preclinical/Patented Drug
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=2727594"></iframe>
3D MOL 2D MOL
PubChem CID
2727594
DME(s) Modulated by This Xenobiotics
DME(s) Inhibited by This Xenobiotics
Cytochrome P450 2C9 (CYP2C9) DME Info Homo sapiens [1]
Cytochrome P450 2D6 (CYP2D6) DME Info Homo sapiens [1]
Cytochrome P450 3A4 (CYP3A4) DME Info Homo sapiens [2]
Lauric acid omega-hydroxylase (CYP4A11) DME Info Homo sapiens [3]
Xenobiotics-DME Activity Data
Xenobiotics-DME Activity Data Cytochrome P450 2C9 (CYP2C9) DME Info IC50 = 3.3 microM [1]
Cytochrome P450 2D6 (CYP2D6) DME Info IC50 = 83.9 microM [1]
Cytochrome P450 3A4 (CYP3A4) DME Info IC50 = 65.4 microM [2]
References
1 Discovery of a N'-hydroxyphenylformamidine derivative HET0016 as a potent and selective 20-HETE synthase inhibitor. Bioorg Med Chem Lett. 2001 Dec 3;11(23):2993-5.
2 Pyrazole and isoxazole derivatives as new, potent, and selective 20-hydroxy-5,8,11,14-eicosatetraenoic acid synthase inhibitors. J Med Chem. 2003 Dec 4;46(25):5416-27.
3 Reverse type I binding spectra of human cytochrome P450 1B1 induced by flavonoid, stilbene, pyrene, naphthalene, phenanthrene, and biphenyl derivatives that inhibit catalytic activity: a structure-function relationship study. Chem Res Toxicol. 2009 Jul;22(7):1325-33.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.